Literature DB >> 2677959

Intraventricular hemorrhage in preterm infants: declining incidence in the 1980s.

A G Philip1, W C Allan, A M Tito, L R Wheeler.   

Abstract

Ultrasound has been routinely used since late 1979 to diagnose periventricular-intraventricular hemorrhage in infants whose gestational age was 34 weeks or less. During the years 1980 to 1987 the ultrasound scans were interpreted by one person, and a steady decline in incidence of periventricular-intraventricular hemorrhage was observed. Both for infants of 34 weeks or less and for very low birth weight (less than 1500 g) infants, periventricular-intraventricular hemorrhage incidence decreased, respectively, from 34% and 39% in 1980 to 1981 to 19% and 25% in 1986 to 1987. This decrease was confined to true intraventricular hemorrhages, which decreased from 22% in 1980 to 1981 to 7% in 1986 to 1987 for infants of less than or equal to 34 weeks' gestation. These results were not influenced by a change in the distribution of birth weights or gestational ages of the infants evaluated nor by a change in the inborn to outborn ratio. The incidence of periventricular-intraventricular hemorrhage was lower in infants born by cesarean section than those delivered vaginally, but the decrease could not be attributed to an increased number of deliveries by cesarean section. Although there were undoubtedly changes in neonatal care during this time period, no planned intervention occurred. It was concluded that pharmacologic intervention studies must be interpreted with caution.

Entities:  

Mesh:

Year:  1989        PMID: 2677959

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  33 in total

1.  The incidence, timing, and predisposing factors of germinal matrix and intraventricular hemorrhage (GMH/IVH) in preterm neonates.

Authors:  Hassan Kadri; Alhakam A Mawla; Jehad Kazah
Journal:  Childs Nerv Syst       Date:  2006-04-25       Impact factor: 1.475

2.  Neonatal complications of extreme prematurity in mechanically ventilated infants.

Authors:  V Chan; A Greenough; H R Gamsu
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

3.  Trends in preterm survival and incidence of cerebral haemorrhage 1980-9.

Authors:  R W Cooke
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

4.  A risk prediction model for severe intraventricular hemorrhage in very low birth weight infants and the effect of prophylactic indomethacin.

Authors:  M J Luque; J L Tapia; L Villarroel; G Marshall; G Musante; W Carlo; J Kattan
Journal:  J Perinatol       Date:  2013-10-10       Impact factor: 2.521

5.  General evaluation of periventricular-intraventricular hemorrhage in premature infants in mainland China.

Authors:  Jing Liu; Li-Wen Chang; Qi Wang; Gui-Lian Qin
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-06-01

6.  Neonatal intracerebral hemorrhage: mechanisms, managements, and the outcomes.

Authors:  P Bouz; A Zouros; A Taha; V Sadanand
Journal:  Transl Stroke Res       Date:  2012-06-06       Impact factor: 6.829

7.  Risk factors for intraventricular haemorrhage in very low birth weight infants.

Authors:  Nilgün Köksal; Birol Baytan; Yusuf Bayram; Ergun Nacarküçük
Journal:  Indian J Pediatr       Date:  2002-07       Impact factor: 1.967

8.  Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants.

Authors:  Olga Romantsik; Matteo Bruschettini; Alvaro Moreira; Bernard Thébaud; David Ley
Journal:  Cochrane Database Syst Rev       Date:  2019-09-24

9.  Randomised trial of parental support for families with very preterm children. Avon Premature Infant Project.

Authors: 
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-07       Impact factor: 5.747

10.  Indomethacin prophylaxis to prevent intraventricular hemorrhage: association between incidence and timing of drug administration.

Authors:  Hussnain Mirza; William Oh; Abbot Laptook; Betty Vohr; Richard Tucker; Barbara S Stonestreet
Journal:  J Pediatr       Date:  2013-03-22       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.